Highline Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-295,653
| Closed | -$12.6M | – | 28 |
|
|
2019
Q3 | $12.6M | Sell |
295,653
-94,800
| -24% | -$4.06M | 1.85% | 18 |
|
|
2019
Q2 | $24.8M | Sell |
390,453
-219,610
| -36% | -$13.9M | 1.81% | 21 |
|
|
2019
Q1 | $42.3M | Buy |
610,063
+151,550
| +33% | +$10.5M | 2.66% | 17 |
|
|
2018
Q4 | $19.9M | Buy |
458,513
+30,393
| +7% | +$1.32M | 1.34% | 23 |
|
|
2018
Q3 | $32.7M | Buy |
428,120
+18,120
| +4% | +$1.38M | 1.51% | 20 |
|
|
2018
Q2 | $31.5M | Buy |
+410,000
| New | +$31.5M | 1.06% | 26 |
|